In-vitro diagnostics BRIC market worth $7.3 billion by 2014
According to a new market research report, In-Vitro Diagnostics (IVD) Market in BRIC (2010 - 2014), the IVD market in the BRIC (Brazil, Russia, India and China) countries is expected to be worth $7.3 billion by 2014, increasing at a compound annual growth rate (CAGR) of 19% from 2009 to 2014.
Market growth is driven mainly by the increasing health care budgets of BRIC economies, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases, says the report published by MarketsandMarkets ( http://www.marketsandmarkets.com).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze